Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-24 @ 7:40 PM
NCT ID:
NCT00026403
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed unresectable adenocarcinoma of the pancreas
* No cystadenocarcinoma of the pancreas or pancreatic tumors of neuroendocrine origin
* Prior subtotal resection or gross residual disease
* No microscopic residual disease only
* No metastatic disease outside of planned study radiotherapy field
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* ECOG 0-1
Life expectancy:
* Not specified
Hematopoietic:
* Absolute neutrophil count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
Hepatic:
* Bilirubin no greater than 2 times upper limit of normal (ULN)
* AST no greater than 3 times ULN
Renal:
* Creatinine no greater than 1.5 times ULN
Other:
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* Able to maintain adequate oral nutrition
* No significant infection
* No other medical condition that would preclude study
* No other malignancy within the past 5 years except non-melanoma skin cancer
* No significant nausea or vomiting
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* No prior or concurrent biologic therapy
Chemotherapy:
* No prior chemotherapy
* No other concurrent chemotherapy
Endocrine therapy:
* Not specified
Radiotherapy:
* See Disease Characteristics
* No prior radiotherapy that would overlap planned study radiotherapy fields
Surgery:
* See Disease Characteristics
* At least 21 days since prior laparotomy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00026403
Study Brief:
Protocol Section:
NCT00026403